Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Influenza

  Free Subscription


21.11.2022

3 Ann Intern Med
1 Antimicrob Agents Chemother
1 Antiviral Res
1 Biochemistry
1 BMC Pediatr
11 BMJ
2 Cell
1 Epidemiol Infect
3 J Clin Microbiol
1 J Exp Med
1 J Gen Virol
1 J Infect
15 J Infect Dis
5 JAMA
1 Lancet
1 Minerva Pediatr (Torino)
2 MMWR Morb Mortal Wkly Rep
9 N Engl J Med
1 PLoS Biol
4 PLoS Med
50 PLoS One
4 Proc Natl Acad Sci U S A
12 Vaccine
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Intern Med

  1. FEKETE T
    In asymptomatic adults, a COVID-19 Ag-RDT with combined nasal and throat samples had 82% to 89% positive percent agreement.
    Ann Intern Med. 2022 Nov 1. doi: 10.7326/J22-0082.
    PubMed         Abstract available

  2. SALANTI G, Peter N, Tonia T, Holloway A, et al
    The Impact of the COVID-19 Pandemic and Associated Control Measures on the Mental Health of the General Population : A Systematic Review and Dose-Response Meta-analysis.
    Ann Intern Med. 2022 Oct 18. doi: 10.7326/M22-1507.
    PubMed         Abstract available

  3. TAN CY, Chiew CJ, Lee VJ, Ong B, et al
    Effectiveness of a Fourth Dose of COVID-19 mRNA Vaccine Against Omicron Variant Among Elderly People in Singapore.
    Ann Intern Med. 2022 Sep 13. doi: 10.7326/M22-2042.
    PubMed        


    Antimicrob Agents Chemother

  4. LINGSCHEID T, Kinzig M, Kruger A, Muller N, et al
    Pharmacokinetics of Nirmatrelvir and Ritonavir in COVID-19 Patients with End-Stage Renal Disease on Intermittent Hemodialysis.
    Antimicrob Agents Chemother. 2022 Oct 26:e0122922. doi: 10.1128/aac.01229.
    PubMed         Abstract available


    Antiviral Res

  5. YANG F, Yan S, Zhu L, Wang FXC, et al
    Evaluation of panel of neutralising murine monoclonal antibodies and a humanised bispecific antibody against influenza A(H1N1)pdm09 virus infection in a mouse model.
    Antiviral Res. 2022 Nov 14:105462. doi: 10.1016/j.antiviral.2022.105462.
    PubMed         Abstract available


    Biochemistry

  6. SASI VM, Ullrich S, Ton J, Fry SE, et al
    Predicting Antiviral Resistance Mutations in SARS-CoV-2 Main Protease with Computational and Experimental Screening.
    Biochemistry. 2022;61:2495-2505.
    PubMed         Abstract available


    BMC Pediatr

  7. ZHOU GY, Penwill NY, Cheng G, Singh P, et al
    Utility of illness symptoms for predicting COVID-19 infections in children.
    BMC Pediatr. 2022;22:655.
    PubMed         Abstract available


    BMJ

  8. MAHASE E
    Covid-19: NICE rejects five treatments over uncertain evidence and price in draft guidance.
    BMJ. 2022;379:o2759.
    PubMed        

  9. BUONSENSO D, Roland D, Yock-Corrales A, Gonzalez-Dambrauskas S, et al
    The challenges of doing paediatric research during the first year of the covid-19 pandemic.
    BMJ. 2022;379:o2750.
    PubMed        

  10. IACOBUCCI G
    Seven day working debate returns, as care backlog grows.
    BMJ. 2022;379:o2754.
    PubMed        

  11. SHEPHERD A
    Covid-19: China eases rules amid rise in cases.
    BMJ. 2022;379:o2743.
    PubMed        

  12. DINSDALE P
    Covid-19: Funding for pandemic preparedness being "sucked away" by war in Ukraine.
    BMJ. 2022;379:o2748.
    PubMed        

  13. WISE J
    RSV: UK to examine whether to offer monoclonal antibody routinely to all babies.
    BMJ. 2022;379:o2725.
    PubMed        

  14. FORTNER R
    AstraZeneca's covid-19 (mis)adventure and the future of vaccine equity.
    BMJ. 2022;379:o2592.
    PubMed        

  15. STOKEL-WALKER C
    How similar is covid-19 to the flu?
    BMJ. 2022;379:o2625.
    PubMed        

  16. UPTON MN
    Covid-19 vaccination in the UK: the Joint Committee on Vaccination and Immunisation's infrastructure.
    BMJ. 2022;379:o2685.
    PubMed        

  17. IACOBUCCI G
    Covid-19: England's health declined in 2020, but not across all areas.
    BMJ. 2022;379:o2710.
    PubMed        

  18. IACOBUCCI G
    Covid-19: Evusheld protects the most vulnerable patients, analysis shows.
    BMJ. 2022;379:o2690.
    PubMed        


    Cell

  19. YAN L, Huang Y, Ge J, Liu Z, et al
    A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analog inhibitors.
    Cell. 2022;185:4347-4360.
    PubMed         Abstract available

  20. BUCKNER CM, Kardava L, El Merhebi O, Narpala SR, et al
    Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses.
    Cell. 2022;185:4333-4346.
    PubMed         Abstract available


    Epidemiol Infect

  21. MAMISHI S, Olfat M, Pourakbari B, Eshaghi H, et al
    Multisystem inflammatory syndrome associated with SARS-CoV-2 infection in children: update and new insights from the second report of an Iranian referral hospital.
    Epidemiol Infect. 2022;150:e179.
    PubMed         Abstract available


    J Clin Microbiol

  22. MACKENZIE C, Batty M, Papadakis G, Stevens L, et al
    Analytical Sensitivity of Lateral Flow Devices against SARS-CoV-2 Omicron Subvariants BA.4, BA.5, and BA.2.75.
    J Clin Microbiol. 2022;60:e0109722.
    PubMed        

  23. PIEWBANG C, Poonsin P, Lohavicharn P, Wardhani SW, et al
    SARS-CoV-2 Transmission from Human to Pet and Suspected Transmission from Pet to Human, Thailand.
    J Clin Microbiol. 2022;60:e0105822.
    PubMed         Abstract available

  24. KEMP TJ, Quesinberry JT, Cherry J, Lowy DR, et al
    Selection, Characterization, Calibration, and Distribution of the U.S. Serology Standard for Anti-SARS-CoV-2 Antibody Detection.
    J Clin Microbiol. 2022;60:e0099522.
    PubMed         Abstract available


    J Exp Med

  25. ONNIS A, Andreano E, Cassioli C, Finetti F, et al
    SARS-CoV-2 Spike protein suppresses CTL-mediated killing by inhibiting immune synapse assembly.
    J Exp Med. 2023;220.
    PubMed         Abstract available


    J Gen Virol

  26. GRAND RJ
    A link between severe hepatitis in children and adenovirus 41 and adeno-associated virus 2 infections.
    J Gen Virol. 2022;103.
    PubMed         Abstract available


    J Infect

  27. CHEN Y, Fan L, Deng W, Lin Q, et al
    Highly Pathogenic Avian Influenza outbreaks amongst bird populations in Europe - a view from China.
    J Infect. 2022 Nov 3. pii: S0163-4453(22)00638.
    PubMed        


    J Infect Dis

  28. LUNA-MUSCHI A, Noguera SV, Borges IC, De Paula AV, et al
    Characterization of SARS-CoV-2 Omicron variant shedding and predictors of viral culture positivity on vaccinated healthcare workers with mild COVID-19.
    J Infect Dis. 2022 Sep 22. pii: 6711076. doi: 10.1093.
    PubMed         Abstract available

  29. AVERY RK, Prono MVD
    Bebtelovimab in the Real World: Promise and Fulfillment.
    J Infect Dis. 2022 Sep 17. pii: 6702587. doi: 10.1093.
    PubMed        

  30. RAZONABLE RR, O'Horo JC, Hanson SN, Arndt RF, et al
    Outcomes of Bebtelovimab Treatment is Comparable to Ritonavir-boosted Nirmatrelvir among High-Risk Patients with Coronavirus Disease-2019 during SARS-CoV-2 BA.2 Omicron Epoch.
    J Infect Dis. 2022 Sep 17. pii: 6702534. doi: 10.1093.
    PubMed         Abstract available

  31. TURCINOVIC J, Schaeffer B, Taylor BP, Bouton TC, et al
    Understanding Early Pandemic Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in a Medical Center by Incorporating Public Sequencing Databases to Mitigate Bias.
    J Infect Dis. 2022;226:1704-1711.
    PubMed         Abstract available

  32. DEWALD F, Detmer S, Pirkl M, Hellmich M, et al
    Viral Load Dynamics in SARS-CoV-2 Omicron Breakthrough Infections.
    J Infect Dis. 2022;226:1721-1725.
    PubMed         Abstract available

  33. VARESE A, Mazzitelli B, Diaz FE, Kjolhede MV, et al
    Omicron breakthrough infection after heterologous prime-boost vaccination induces a vigorous antibody response.
    J Infect Dis. 2022 Jun 20. pii: 6611839. doi: 10.1093.
    PubMed         Abstract available

  34. LEMASTER C, Geanes ES, Fraley ER, Selvarangan R, et al
    Vaccination after SARS-CoV-2 infection increased antibody avidity against the Omicron variant compared to vaccination alone.
    J Infect Dis. 2022 Jun 18. pii: 6609994. doi: 10.1093.
    PubMed         Abstract available

  35. HAKRE S, Lakhal-Naouar I, King DB, Burns JL, et al
    Virological and Serological Assessment of US Army Trainees Isolated for Coronavirus Disease 2019.
    J Infect Dis. 2022;226:1743-1752.
    PubMed         Abstract available

  36. EL SAHLY HM, Baden LR, Essink B, Montefiori D, et al
    Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 COVE Trial.
    J Infect Dis. 2022 May 10. pii: 6583011. doi: 10.1093.
    PubMed         Abstract available

  37. MELLIS AM, Meece JK, Halasa NB, Chappell JD, et al
    SARS-CoV-2 Virus Dynamics in Recently Infected People-Data From a Household Transmission Study.
    J Infect Dis. 2022;226:1699-1703.
    PubMed         Abstract available

  38. BALTRUSAITIS K, Reed C, Sewalk K, Brownstein JS, et al
    Healthcare-Seeking Behavior for Respiratory Illness Among Flu Near You Participants in the United States During the 2015-2016 Through 2018-2019 Influenza Seasons.
    J Infect Dis. 2022;226:270-277.
    PubMed         Abstract available

  39. WAGHMARE A, Krantz EM, Baral S, Vasquez E, et al
    Reliability of Self-Sampling for Accurate Assessment of Respiratory Virus Viral and Immunologic Kinetics.
    J Infect Dis. 2022;226:278-286.
    PubMed         Abstract available

  40. O'NEIL B, Ison MG, Hallouin-Bernard MC, Nilsson AC, et al
    A Phase 2 Study of Pimodivir (JNJ-63623872) in Combination With Oseltamivir in Elderly and Nonelderly Adults Hospitalized With Influenza A Infection: OPAL Study.
    J Infect Dis. 2022;226:109-118.
    PubMed         Abstract available

  41. HOA LNM, Sullivan SG, Mai LQ, Khvorov A, et al
    Influenza A(H1N1)pdm09 But Not A(H3N2) Virus Infection Induces Durable Seroprotection: Results From the Ha Nam Cohort.
    J Infect Dis. 2022;226:59-69.
    PubMed         Abstract available

  42. SKOWRONSKI DM, Leir S, Sabaiduc S, Chambers C, et al
    Influenza Vaccine Effectiveness by A(H3N2) Phylogenetic Subcluster and Prior Vaccination History: 2016-2017 and 2017-2018 Epidemics in Canada.
    J Infect Dis. 2022;225:1387-1398.
    PubMed         Abstract available


    JAMA

  43. YEK C, Kadri SS
    Massachusetts Data on Excess Mortality During the Delta and Omicron Waves of COVID-19.
    JAMA. 2022;328:1977.
    PubMed        

  44. FAUST JS, Renton B, Du C
    Massachusetts Data on Excess Mortality During the Delta and Omicron Waves of COVID-19.
    JAMA. 2022;328:1977-1978.
    PubMed        

  45. LARKIN HD
    COVID-19 Limited Access to Sexual and Reproductive Health Services.
    JAMA. 2022;328:1896-1897.
    PubMed        

  46. KUEHN BM
    Second COVID-19 Booster Increases Protection for Nursing Home Patients.
    JAMA. 2022;328:1800-1801.
    PubMed        

  47. BERNARD SA, Bray JE, Smith K, Stephenson M, et al
    Effect of Lower vs Higher Oxygen Saturation Targets on Survival to Hospital Discharge Among Patients Resuscitated After Out-of-Hospital Cardiac Arrest: The EXACT Randomized Clinical Trial.
    JAMA. 2022 Oct 26. pii: 2798013. doi: 10.1001/jama.2022.17701.
    PubMed         Abstract available


    Lancet

  48. MESSACAR K, Baker RE, Park SW, Nguyen-Tran H, et al
    Preparing for uncertainty: endemic paediatric viral illnesses after COVID-19 pandemic disruption.
    Lancet. 2022 Jul 14. pii: S0140-6736(22)01277.
    PubMed        


    Minerva Pediatr (Torino)

  49. LYTVYN H, Stasiv M, Basa N, Kulachkovska I, et al
    Multisystem inflammatory syndrome in children associated with SARS-CoV-2 infection and severe abdominal syndrome: the Lviv "OHMATDYT" (Western Ukraine) experience.
    Minerva Pediatr (Torino). 2022;74:600-608.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  50. ROSENBLUM HG, Wallace M, Godfrey M, Roper LE, et al
    Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines - United States, October 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1436-1441.
    PubMed         Abstract available

  51. HAMID S, Woodworth K, Pham H, Milucky J, et al
    COVID-19-Associated Hospitalizations Among U.S. Infants Aged <6 Months - COVID-NET, 13 States, June 2021-August 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1442-1448.
    PubMed         Abstract available


    N Engl J Med

  52. RUBIN EJ, Baden LR, Marks P, Morrissey S, et al
    Audio Interview: The FDA and Covid-19 Vaccines.
    N Engl J Med. 2022;387:e60.
    PubMed        

  53. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Masking and Covid-19.
    N Engl J Med. 2022;387:e56.
    PubMed        

  54. VENKATARAMANI V, Winkler F
    Cognitive Deficits in Long Covid-19.
    N Engl J Med. 2022;387:1813-1815.
    PubMed        

  55. FRICCHIONE GL, Paul AB, Chemali Z, Kritzer MD, et al
    Case 34-2022: A 57-Year-Old Woman with Covid-19 and Delusions.
    N Engl J Med. 2022;387:1795-1803.
    PubMed        

  56. GOLDEN MR, Wasserheit JN
    Monkeypox - A Sobering Sentinel for Pandemic Preparedness and Sexual Health System Capacity.
    N Engl J Med. 2022;387:1826-1829.
    PubMed        

  57. CHEMAITELLY H, AlMukdad S, Ayoub HH, Altarawneh HN, et al
    Covid-19 Vaccine Protection among Children and Adolescents in Qatar.
    N Engl J Med. 2022 Nov 2. doi: 10.1056/NEJMoa2210058.
    PubMed         Abstract available

  58. CHIN ET, Leidner D, Lamson L, Lucas K, et al
    Protection against Omicron from Vaccination and Previous Infection in a Prison System.
    N Engl J Med. 2022 Oct 26. doi: 10.1056/NEJMoa2207082.
    PubMed         Abstract available

  59. WITBERG G, Magen O, Hoss S, Talmor-Barkan Y, et al
    Myocarditis after BNT162b2 Vaccination in Israeli Adolescents.
    N Engl J Med. 2022 Oct 19. doi: 10.1056/NEJMc2207270.
    PubMed        

  60. HACHMANN NP, Miller J, Collier AY, Barouch DH, et al
    Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.4.6.
    N Engl J Med. 2022 Oct 19. doi: 10.1056/NEJMc2212117.
    PubMed        


    PLoS Biol

  61. GARCIA G JR, Jeyachandran AV, Wang Y, Irudayam JI, et al
    Hippo signaling pathway activation during SARS-CoV-2 infection contributes to host antiviral response.
    PLoS Biol. 2022;20:e3001851.
    PubMed         Abstract available


    PLoS Med

  62. SUTHAR AB, Dye C
    Infection, immunity, and surveillance of COVID-19.
    PLoS Med. 2022;19:e1004132.
    PubMed         Abstract available

  63. BERGERI I, Whelan MG, Ware H, Subissi L, et al
    Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies.
    PLoS Med. 2022;19:e1004107.
    PubMed         Abstract available

  64. ROESSLER M, Tesch F, Batram M, Jacob J, et al
    Post-COVID-19-associated morbidity in children, adolescents, and adults: A matched cohort study including more than 157,000 individuals with COVID-19 in Germany.
    PLoS Med. 2022;19:e1004122.
    PubMed         Abstract available

  65. BERTRAN M, Amin-Chowdhury Z, Davies HG, Allen H, et al
    COVID-19 deaths in children and young people in England, March 2020 to December 2021: An active prospective national surveillance study.
    PLoS Med. 2022;19:e1004118.
    PubMed         Abstract available


    PLoS One

  66. MUNCH PK, Espenhain L, Hansen CH, Krause TG, et al
    Case-control study of activities associated with SARS-CoV-2 infection in an adult unvaccinated population and overview of societal COVID-19 epidemic counter measures in Denmark.
    PLoS One. 2022;17:e0268849.
    PubMed         Abstract available

  67. APPLEBY G, Papageorgiou V, Horter S, Wharton-Smith A, et al
    Caregiver perceptions and experiences of paediatric emergency department attendance during the COVID-19 pandemic: A mixed-methods study.
    PLoS One. 2022;17:e0276055.
    PubMed         Abstract available

  68. BAJRAI LH, Faizo AA, Alkhaldy AA, Dwivedi VD, et al
    Repositioning of anti-dengue compounds against SARS-CoV-2 as viral polyprotein processing inhibitor.
    PLoS One. 2022;17:e0277328.
    PubMed         Abstract available

  69. RAHMAN M, Datta PK, Islam K, Haque M, et al
    Efficacy of colchicine in patients with moderate COVID-19: A double-blinded, randomized, placebo-controlled trial.
    PLoS One. 2022;17:e0277790.
    PubMed         Abstract available

  70. ALTENDAHL M, Mok T, Jang C, Yeo S, et al
    Severe COVID-19 in pregnancy has a distinct serum profile, including greater complement activation and dysregulation of serum lipids.
    PLoS One. 2022;17:e0276766.
    PubMed         Abstract available

  71. DAI Z, Xiao W, Wang H, Wu Y, et al
    Influencing factors of anxiety and depression of discharged COVID-19 patients in Wuhan, China.
    PLoS One. 2022;17:e0276608.
    PubMed         Abstract available

  72. ALANAZI MA, El-Hiti GA, Alotaibi R, Baashen MA, et al
    Effect of surgical face mask wearing on tear film in women with a high body mass index.
    PLoS One. 2022;17:e0277803.
    PubMed         Abstract available

  73. RAIFMAN J, Ettman CK, Dean LT, Abdalla SM, et al
    Economic precarity, loneliness, and suicidal ideation during the COVID-19 pandemic.
    PLoS One. 2022;17:e0275973.
    PubMed         Abstract available

  74. AL BLOOSHI M, Al Ameri T, Al Marri M, Ahmad A, et al
    The impact of COVID-19 pandemic on depression and anxiety symptoms: Findings from the United Arab Emirates Healthy Future (UAEHFS) cohort study.
    PLoS One. 2022;17:e0277684.
    PubMed         Abstract available

  75. HOSSAIN MA, Shafin R, Ahmed MS, Rana MS, et al
    Health-related quality of life and coping strategies adopted by COVID-19 survivors: A nationwide cross-sectional study in Bangladesh.
    PLoS One. 2022;17:e0277694.
    PubMed         Abstract available

  76. KUNDU A, Fu R, Grace D, Logie CH, et al
    Correlates of wanting to seek help for mental health and substance use concerns by sexual and gender minority young adults during the COVID-19 pandemic: A machine learning analysis.
    PLoS One. 2022;17:e0277438.
    PubMed         Abstract available

  77. NWOSU L, Li X, Qian L, Kim S, et al
    Calibrated bagging deep learning for image semantic segmentation: A case study on COVID-19 chest X-ray image.
    PLoS One. 2022;17:e0276250.
    PubMed         Abstract available

  78. NEWCOMB K, Bilal S, Michael E
    Combining predictive models with future change scenarios can produce credible forecasts of COVID-19 futures.
    PLoS One. 2022;17:e0277521.
    PubMed         Abstract available

  79. SOUSA FILHO JF, Silva UM, Lima LL, Paiva ASS, et al
    Association of urban inequality and income segregation with COVID-19 mortality in Brazil.
    PLoS One. 2022;17:e0277441.
    PubMed         Abstract available

  80. BANU B, Akter N, Chowdhury SH, Islam KR, et al
    COVID-19 and Bangladeshi health professionals: Infection status, vaccination and its immediate health consequences.
    PLoS One. 2022;17:e0277022.
    PubMed         Abstract available

  81. LIAO KT, Villarreal A
    Unequal effects of the COVID-19 epidemic on employment: Differences by immigrant status and race/ethnicity.
    PLoS One. 2022;17:e0277005.
    PubMed         Abstract available

  82. PEREZ A, Johnson JK, Marquez DX, Keiser S, et al
    Factors related to COVID-19 vaccine intention in Latino communities.
    PLoS One. 2022;17:e0272627.
    PubMed         Abstract available

  83. TAKADA R, Takazawa T, Takahashi Y, Fujizuka K, et al
    Risk factors for mechanical ventilation and ECMO in COVID-19 patients admitted to the ICU: A multicenter retrospective observational study.
    PLoS One. 2022;17:e0277641.
    PubMed         Abstract available

  84. LEE H, Noh EB, Kim JE, Oh J, et al
    Influencing factor of COVID-19 vaccination trust and hesitancy in Wonju city, South Korea.
    PLoS One. 2022;17:e0277016.
    PubMed         Abstract available

  85. NASH M, Leane E, Norris K
    It's just that uncertainty that eats away at people: Antarctic expeditioners' lived experiences of COVID-19.
    PLoS One. 2022;17:e0277676.
    PubMed         Abstract available

  86. BASELER HA, Aksoy M, Salawu A, Green A, et al
    The negative impact of COVID-19 on working memory revealed using a rapid online quiz.
    PLoS One. 2022;17:e0269353.
    PubMed         Abstract available

  87. CAGGIARI S, Keenan B, Bader DL, Mavrogordato MN, et al
    A combined imaging, deformation and registration methodology for predicting respirator fitting.
    PLoS One. 2022;17:e0277570.
    PubMed         Abstract available

  88. DU MONT J, Lebel N, Coelho M, Friedman Burley J, et al
    Advancing community-engaged research during the COVID-19 pandemic: Insights from a social network analysis of the trans-LINK Network.
    PLoS One. 2022;17:e0271397.
    PubMed         Abstract available

  89. AL-ABDI T, Heraclides A, Papageorgiou A, Philippou E, et al
    Impact of the COVID-19 lockdown on lifestyle behaviors and their association with personality among adults in Qatar: A cross-sectional study.
    PLoS One. 2022;17:e0276426.
    PubMed         Abstract available

  90. CEMBERCI M, Civelek ME, Ertemel AV, Comert PN, et al
    The relationship of work engagement with job experience, marital status and having children among flexible workers after the Covid-19 pandemic.
    PLoS One. 2022;17:e0276784.
    PubMed         Abstract available

  91. ZAMANI S, Alizadeh M, Shahrestanaki E, Mohammadpoor Nami S, et al
    Prognostic comparison of COVID-19 outpatients and inpatients treated with Remdesivr: A retrospective cohort study.
    PLoS One. 2022;17:e0277413.
    PubMed         Abstract available

  92. AI Y, He F, Lancaster E, Lee J, et al
    Application of machine learning for multi-community COVID-19 outbreak predictions with wastewater surveillance.
    PLoS One. 2022;17:e0277154.
    PubMed         Abstract available

  93. KAREEM R, Sethi MR, Inayat S, Irfan M, et al
    The effect of COVID-19 vaccination on the menstrual pattern and mental health of the medical students: A mixed-methods study from a low and middle-income country.
    PLoS One. 2022;17:e0277288.
    PubMed         Abstract available

  94. SIAMISANG K, Mokgethi N, Lesetedi O, Selemogo M, et al
    Knowledge, attitudes and preventive practices towards COVID-19 among workers at two points of entry in South-Eastern Botswana: A cross-sectional study.
    PLoS One. 2022;17:e0277506.
    PubMed         Abstract available

  95. ELEUTERIO TA, Oliveira MC, Velasco MDS, Menezes RA, et al
    SARS due to COVID-19: Predictors of death and profile of adult patients in the state of Rio de Janeiro, 2020.
    PLoS One. 2022;17:e0277338.
    PubMed         Abstract available

  96. HERRMANN-WERNER A, Erschens R, Zipfel S, Festl-Wietek T, et al
    Where there are challenges, there are opportunities: An undergraduate medical students' teaching concept for mental health in times of COVID-19.
    PLoS One. 2022;17:e0277525.
    PubMed         Abstract available

  97. MORISHIMA M, Kimura M, Sakoh T, Yamamuro R, et al
    Universal admission screening for COVID-19 using quantitative antigen testing and questionnaire screening to prevent nosocomial spread.
    PLoS One. 2022;17:e0277426.
    PubMed         Abstract available

  98. BRACCI A, Nadini M, Aliapoulios M, McCoy D, et al
    Vaccines and more: The response of Dark Web marketplaces to the ongoing COVID-19 pandemic.
    PLoS One. 2022;17:e0275288.
    PubMed         Abstract available

  99. DE FORNI D, Poddesu B, Cugia G, Chafouleas J, et al
    Synergistic drug combinations designed to fully suppress SARS-CoV-2 in the lung of COVID-19 patients.
    PLoS One. 2022;17:e0276751.
    PubMed         Abstract available

  100. MARTINEZ MA
    What do people write about COVID-19 and teaching, publicly? Insulators and threats to newly habituated and institutionalized practices for instruction.
    PLoS One. 2022;17:e0276511.
    PubMed         Abstract available

  101. EL GUERCHE-SEBLAIN C, Etcheto A, Parmentier F, Afshar M, et al
    Hospital admissions with influenza and impact of age and comorbidities on severe clinical outcomes in Brazil and Mexico.
    PLoS One. 2022;17:e0273837.
    PubMed         Abstract available

  102. VAN DER VELDEN PG, Marchand M, Das M, Muffels R, et al
    The prevalence, incidence, and risk factors of mental health problems and mental health service use before and 9 months after the COVID-19 outbreak among the general Dutch population. A 3-wave prospective study.
    PLoS One. 2022;17:e0276834.
    PubMed         Abstract available

  103. DONOVAN-BANFIELD I, Milligan R, Hall S, Gao T, et al
    Direct RNA sequencing of respiratory syncytial virus infected human cells generates a detailed overview of RSV polycistronic mRNA and transcript abundance.
    PLoS One. 2022;17:e0276697.
    PubMed         Abstract available

  104. IDE K, Asami T, Suda A, Yoshimi A, et al
    The psychological distress and suicide-related ideation in hospital workers during the COVID-19 pandemic: Second results from repeated cross-sectional surveys.
    PLoS One. 2022;17:e0277174.
    PubMed         Abstract available

  105. TAYLOR S, Rachor GS, Asmundson GJG
    Who develops pandemic fatigue? Insights from Latent Class Analysis.
    PLoS One. 2022;17:e0276791.
    PubMed         Abstract available

  106. KWABLA MP, Nyasordzi J, Kye-Duodu G, Ananga MK, et al
    Factors associated with COVID-19 knowledge among Ghanaians: A national survey.
    PLoS One. 2022;17:e0276381.
    PubMed         Abstract available

  107. BARTELS SL, Shaaban CE, Brum WS, Welikovitch LA, et al
    Impact of the COVID-19 pandemic on early career dementia researchers: A global online survey.
    PLoS One. 2022;17:e0277470.
    PubMed         Abstract available

  108. SAKAMOTO M, Ishizuka R, Ozawa C, Fukuda Y, et al
    Health information and COVID-19 vaccination: Beliefs and attitudes among Japanese university students.
    PLoS One. 2022;17:e0277435.
    PubMed         Abstract available

  109. SHESTAKOVA M, Kononenko I, Kalmykovsmall a, Cyrillic Z, Markova T, et al
    Glycated hemoglobin level dynamics in COVID-19 survivors: 12 months follow-up study after discharge from hospital.
    PLoS One. 2022;17:e0275381.
    PubMed         Abstract available

  110. SHANTHA JG, Fashina T, Stittleburg V, Randleman C, et al
    COVID-19 and the eye: Systemic and laboratory risk factors for retinopathy and detection of tear film SARS-CoV-2 RNA with a triplex RT-PCR assay.
    PLoS One. 2022;17:e0277301.
    PubMed         Abstract available

  111. ALJABERI MA, Alareqe NA, Alsalahi A, Qasem MA, et al
    A cross-sectional study on the impact of the COVID-19 pandemic on psychological outcomes: Multiple indicators and multiple causes modeling.
    PLoS One. 2022;17:e0277368.
    PubMed         Abstract available

  112. PAVEY H, Kulkarni S, Wood A, Ben-Shlomo Y, et al
    Primary hypertension, anti-hypertensive medications and the risk of severe COVID-19 in UK Biobank.
    PLoS One. 2022;17:e0276781.
    PubMed         Abstract available

  113. DALTON M, Dougall P, Amoah Darko FL, Annan W, et al
    Modeling optimal reopening strategies for COVID-19 and its variants by keeping infections low and fixing testing capacity.
    PLoS One. 2022;17:e0274407.
    PubMed         Abstract available

  114. TAMMINGA GG, Jansen GJ, Wiersma M
    Evaluation of a fluorescence in situ hybridization (FISH)-based method for detection of SARS-CoV-2 in saliva.
    PLoS One. 2022;17:e0277367.
    PubMed         Abstract available

  115. ESCRIVA-MARTINEZ T, Vara MD, Czeraniuk N, Denis M, et al
    mHealth intervention to improve quality of life in patients with chronic diseases during the COVID-19 crisis in Paraguay: A study protocol for a randomized controlled trial.
    PLoS One. 2022;17:e0273290.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  116. BOYLE L, Hletko S, Huang J, Lee J, et al
    Selective sweeps in SARS-CoV-2 variant competition.
    Proc Natl Acad Sci U S A. 2022;119:e2213879119.
    PubMed         Abstract available

  117. CONSTANTINO SM, Cooperman AD, Keohane RO, Weber EU, et al
    Personal hardship narrows the partisan gap in COVID-19 and climate change responses.
    Proc Natl Acad Sci U S A. 2022;119:e2120653119.
    PubMed         Abstract available

  118. HE Q, Xie Y
    The moral filter of patriotic prejudice: How Americans view Chinese in the COVID-19 era.
    Proc Natl Acad Sci U S A. 2022;119:e2212183119.
    PubMed         Abstract available

  119. GARRY RF
    The evidence remains clear: SARS-CoV-2 emerged via the wildlife trade.
    Proc Natl Acad Sci U S A. 2022;119:e2214427119.
    PubMed        


    Vaccine

  120. JACKSON ML, Phillips CH, Wellwood S, Kiniry E, et al
    Burden of medically attended influenza infection and cases averted by vaccination - United States, 2016/17 through 2018/19 influenza seasons.
    Vaccine. 2022 Nov 12. pii: S0264-410X(22)01397.
    PubMed         Abstract available

  121. KPOZEHOUEN EB, Tan T, Macintyre CR
    Uptake of influenza, pneumococcal and herpes zoster vaccines among people with heart failure and atrial fibrillation.
    Vaccine. 2022 Nov 12. pii: S0264-410X(22)01377.
    PubMed         Abstract available

  122. PANICKAN S, Bhatia S, Bhat S, Bhandari N, et al
    Reverse genetics based H5N2 vaccine provides clinical protection against H5N1, H5N8 and H9N2 avian influenza infection in chickens.
    Vaccine. 2022;40:6998-7008.
    PubMed         Abstract available

  123. ALFANO V, Ercolano S
    Your vaccine attitude determines your altitude. What are the determinants of attitudes toward vaccination?
    Vaccine. 2022;40:6987-6997.
    PubMed         Abstract available

  124. TURBYFILL C, Adams K, Tenforde MW, Murray NL, et al
    Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States.
    Vaccine. 2022;40:6979-6986.
    PubMed         Abstract available

  125. KULKARNI AV, Jaggaiahgari S, Iyengar S, Simhadri V, et al
    Poor immune response to coronavirus disease vaccines in decompensated cirrhosis patients and liver transplant recipients.
    Vaccine. 2022;40:6971-6978.
    PubMed         Abstract available

  126. SUN R, Budhwani H
    Negative sentiments toward novel coronavirus (COVID-19) vaccines.
    Vaccine. 2022 Oct 21. pii: S0264-410X(22)01297.
    PubMed         Abstract available

  127. PHOKSAWAT W, Nithichanon A, Lerdsamran H, Wongratanacheewin S, et al
    Phenotypic and functional changes of T cell subsets after CoronaVac vaccination.
    Vaccine. 2022 Oct 22. pii: S0264-410X(22)01265.
    PubMed         Abstract available

  128. HE H, Zhu Y, Jin M, Zhou Y, et al
    The decline in immunity and circulation of pertussis among Chinese population during the COVID-19 pandemic: A cross-sectional sero-epidemiological study.
    Vaccine. 2022;40:6956-6962.
    PubMed         Abstract available

  129. SANTIBANEZ TA, Black CL, Vogt TM, Chatham-Stephens K, et al
    Where are children ages 5-17 years receiving their COVID-19 vaccinations? Variations over time and by sociodemographic characteristics, United States.
    Vaccine. 2022 Oct 20. pii: S0264-410X(22)01282.
    PubMed         Abstract available

  130. STONER MCD, Tweedy D, Comello MGL, Toval C, et al
    Using narratives to inform the development of a digital health intervention related to COVID-19 vaccination in Black young adults in Georgia, North Carolina and Alabama.
    Vaccine. 2022 Oct 20. pii: S0264-410X(22)01286.
    PubMed         Abstract available

  131. ZHONG VW, Li X, Ran J, Hu G, et al
    Vaccination, symptomatic infection and negative conversion of viral RNA by body mass index, diabetes, and age: An observational study.
    Vaccine. 2022 Oct 20. pii: S0264-410X(22)01262.
    PubMed         Abstract available


    Virology

  132. LIANG Y, Hjulsager CK, Seekings AH, Warren CJ, et al
    Pathogenesis and infection dynamics of high pathogenicity avian influenza virus (HPAIV) H5N6 (clade 2.3.4.4b) in pheasants and onward transmission to chickens.
    Virology. 2022;577:138-148.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: